(Q33977497)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

main subject

gram-positive bacteria

0 references

1 reference

1 reference

1

Noskin GA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

5

Peterson LR

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

4

Hacek D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

3

Stosor V

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

Siddiqui F

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

2059-2062

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin

10 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, an

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

Major trends in the microbial etiology of nosocomial infection.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89415

Control of endemic glycopeptide-resistant enterococci

5 July 2018

1 reference

12 December 2020

Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients

1 reference

12 December 2020

Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci

1 reference

12 December 2020

Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.43.8.2059

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428937%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference